Skip to main content
OpenTrials
Completed

NCT Number: NCT07025837

The Effects of an LED Face Mask & Neck and Chest Mask On Skin Health

This 12-week single-group virtual study evaluates the effects of the iRESTORE Illumina LED Face Mask and Neck & Chest Mask on skin health in adult females. Participants will use the devices daily for 10 minutes and complete scheduled surveys and photographs to assess improvements in skin appearance via both dermatologist assessment and participant perception.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Skin Aging Sun Damaged Skin

Age range

25 year–55 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Las Vegas, Nevada, 89118, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Female
  • Aged 25-55 years.
  • Willing to follow the study protocols.
  • Self-reported issues with at least two of the following: Fine lines, Wrinkles, Hyperpigmentation, Dark spots, Reduced elasticity
  • Self-report concerns with at least one of the following: Crepey skin on the neck and chest, Sun damage on neck and chest
  • Willing to avoid introducing any new products, prescription medications, or supplements that target skin health during the study period.
  • If taking oral supplements or herbal remedies targeted at skin health and appearance, have been consistently taking these for at least 3 months prior to starting the study.
  • Is willing to maintain the routine of any oral supplements or herbal remedies targeted at skin health and appearance for the duration of the study.
  • Has been using the same skincare routine for at least one month prior to the study start date.
  • Willing to maintain the same skincare routine and products throughout the study.
  • Willing to avoid direct sun exposure during the study duration
  • Willing to wear sunscreen if have to be in the sun

Exclusion criteria

  • Anyone who is extremely satisfied with their skin.
  • Anyone who has any chronic health conditions such as oncological (cancer) or psychiatric disorders.
  • Anyone who is planning to undergo facial treatments during the study period, including botox, dermal filler, chemical peels, etc. or has experienced any of these treatments in the last 3 months.
  • Anyone diagnosed with a skin condition affecting the face and/or neck who has had an active flare-up or breakout within the last year. This includes but is not limited to acne, eczema, psoriasis, rosacea, seborrheic dermatitis, vitiligo, urticaria (hives), warts, atopic dermatitis, melasma, and contact dermatitis.
  • Currently using any prescription medications that may affect the skin condition including but not limited to the following:
  • Corticosteroids like prednisone, methylprednisolone
  • Antipsychotics like olanzapine (Zyprexa), risperidone (Risperdal), quetiapine (Seroquel)
  • SSRIs and SNRIs like fluoxetine (Prozac), sertraline (Zoloft), venlafaxine (Effexor)
  • Anticonvulsants like phenytoin (Dilantin), lamotrigine (Lamictal), and carbamazepine (Tegretol)
  • Antihypertensives like lisinopril (Zestril), amlodipine (Norvasc), and propranolol (Inderal)
  • Antithyroid medications like Tapazole (methimazole), Propyl-Thyracil (propylthiouracil)
  • Anyone with a history of skin cancer or precancerous skin lesions on the face.
  • Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
  • Anyone who has any known allergies to ingredients commonly found in skincare products.
  • Anyone who is pregnant, breastfeeding, or trying to conceive
  • Anyone who cannot/will not commit to the study protocol.
  • Anyone with a history of substance abuse.
  • Anyone who has undergone an invasive medical procedure in the three weeks prior to the study or has a procedure planned during the study duration.
  • Anyone with a known allergic reaction to aluminum or plastics.
  • Anyone who suffers from any photosensitive disorder (sensitization to light).
  • Anyone with uncontrolled acne.
  • Anyone taking any prescription medication, over-the-counter supplements, or herbal supplements regularly (three or more days per week) that can cause photosensitivity including but not limited to the following:
  • Antibiotics like tetracyclines (e.g., doxycycline, tetracycline) or sulfonamides (e.g., Bactrim), fluoroquinolones (e.g., ciprofloxacin, levofloxacin)
  • Antifungals like Griseofulvin or Vfend (voriconazole)
  • Diuretics like drugs ending in -thiazides
  • NSAIDs like ibuprofen and Aleve (naproxen)
  • Retinoids or Vitamin A (e.g., Accutane (isotretinoin), (Retin-A) tretinoin
  • Antidepressants (e.g., SSRIs, Elavil (amitriptyline), Tofranil (imipramine)
  • Antihistamines like Phenergan (promethazine)
  • Antimalarial medications
  • Statins like Lipitor (atorvastatin), Zocor (simvastatin)
  • Antiarrhythmics like Pacerone (amiodarone)
  • St. John's wort
  • Anyone who suffers from light-induced headaches or migraines.
  • Anyone with a medical history of seizures or epilepsy triggered by light.
  • Anyone with an electronic implanted device such as a defibrillator, neurostimulator, pacemaker, or ECG monitor.
  • Anyone with a known history of carotid artery disease, stroke or transient ischemic attack (TIA), carotid stenosis, unstable blood pressure, easy fainting, thyroid disease, or of individuals about to undergo surgical procedures in the neck area.
  • Anyone who has stopped hormonal birth control in the past month.

Treatment and study plan

iRESTORE Illumina LED Face Mask and Neck & Chest Mask

Device

A pair of light-emitting diode (LED) therapy devices designed for at-home use. The facial and neck/chest masks deliver low-level red light therapy through embedded LEDs to improve visible signs of skin aging.

Primary outcomes

  1. Percentage of Participants Reported as Having an Improvement in Overall Skin Health as Evaluated by Dermatologist Grading

    Time frame: Baseline, Week 12

    Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in overall skin health.

  2. Percentage of Participants Reported as Having an Improvement in Fine Lines and Wrinkles as Evaluated by Dermatologist Grading

    Time frame: Baseline, Week 12

    Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in fine lines and wrinkles.

  3. Percentage of Participants Reported as Having an Improvement in Skin Pigmentation as Evaluated by Dermatologist Grading

    Time frame: Baseline, Week 12

    Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in skin pigmentation.

  4. Percentage of Participants Reported as Having an Improvement in Skin Redness as Evaluated by Dermatologist Grading

    Time frame: Baseline, Week 12.

    Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in skin redness.

  5. Percentage of Participants Reported as Having an Improvement in Signs of Aging as Evaluated by Dermatologist Grading.

    Time frame: Baseline, Week 12

    Participants will submit photos, which are reviewed by dermatologists using a standardized grading system to evaluate visible changes in signs of aging.

Secondary outcomes

  1. Self-Reported Improvement in Overall Skin Hydration

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for overall skin hydration from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale for skin hydration, including Extremely Dry (=1), Mildly Dry (=2), Neither dry nor hydrated (=3), Hydrated with room for improvement (=4), and Optimally hydrated (=5). Higher scores indicate greater improvement. This is a positively weighted item.

  2. Self-Reported Improvement in Skin Plumpness

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for skin plumpness from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of plumpness, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.

  3. Self-Reported Improvement in Skin Tone

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for skin tone from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale for skin tone, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.

  4. Self-Reported Improvement in Skin Texture

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for skin texture from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of skin texture, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.

  5. Self-Reported Improvement in Facial Skin Glow

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for facial skin glow from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of facial skin glow, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.

  6. Self-Reported Improvement in Facial Skin Health

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for facial skin health from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of facial skin health, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.

  7. Self-Reported Improvement in Facial Skin Appearance

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for facial skin appearance from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of facial skin appearance, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.

  8. Self-Reported Improvement in Skin Tone Evenness.

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for skin tone evenness from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of skin tone evenness, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.

  9. Self-Reported Improvement in Facial Skin Clarity

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for facial skin clarity from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of facial skin clarity, including Very bad (=1), Bad (=2), Neither good nor bad (=3), Good (=4), and Very good (=5). Higher scores indicate greater improvement. This is a positively weighted item.

  10. Self-Reported Improvement in Lift and Firmness of Skin

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for lift and firmness of skin from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of skin lift and firmness, including Not at all (=1), A little bit (=2), Somewhat (=3), Very much (=4), and Extremely (=5). Higher scores indicate greater improvement. This is a positively weighted item.

  11. Self-Reported Improvement in the Severity of Skin Redness

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for severity of skin redness from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of skin redness severity, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.

  12. Self-Reported Improvement in the Severity of 'Crepey' Skin on the Neck & Chest

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for the severity of 'crepey' skin on the neck & chest from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of 'crepey' skin severity, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.

  13. Self-Reported Improvement in the Severity of Dark Spots on the Skin of the Neck and Chest

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for the severity of dark spots on the skin of the neck and chest from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of dark spot severity, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.

  14. Self-Reported Improvement in the Visibility of Fine Lines and Wrinkles on the Skin of the Neck and Chest.

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for the visibility of fine lines and wrinkles on the skin of the neck and chest from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of fine line and wrinkle visibility, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.

  15. Self-Reported Improvement in the Severity of Sagging on the Neck

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for the severity of sagging on the neck from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of sagging severity, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.

  16. Self-Reported Improvement in the Severity of Hyperpigmentation

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for the severity of hyperpigmentation from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of hyperpigmentation, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.

  17. Self-Reported Improvement in the Visibility of Facial Scars or Blemishes

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for the visibility of facial scars or blemishes from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of scar or blemish visibility, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.

  18. Self-Reported Improvement in the Visibility of Any Fine Lines and Wrinkles

    Time frame: Baseline, Week 2, Week 4, Week 6, Week 8, Week 10, Week 12

    This outcome measures the change in participant-reported scores for the visibility of any fine lines and wrinkles from baseline to Week 2, Week 4, Week 6, Week 8, Week 10, and Week 12, using a study-specific questionnaire. Each parameter was scored on a 5-point Likert scale of fine line and wrinkle visibility, including Not noticeable (=1), Barely noticeable (=2), Moderate (=3), Distracting (=4), and Severe (=5). Lower scores indicate greater improvement. This is a negatively weighted item.

Sponsors and collaborators

Lead sponsor

Freedom Laser, Inc.

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 18, 2025
Registry last updated
Oct 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.